DAYCLING (ISTK3)


Welcome to the PulseAid listing for the DAYCLING drug offered from ISTK3. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: ISTK3
NON-PROPRIETARY NAME: magnesium stearate
SUBSTANCE NAME: MAGNESIUM STEARATE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: VAGINAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2017-10-24
END MARKETING DATE: 0000-00-00


DAYCLING HUMAN OTC DRUG Details:

Item DescriptionDAYCLING from ISTK3
LABELER NAME: ISTK3
DEA SCHEDULE:
ACTIVE STRENGTH: 5(mg/1)
START MARKETING DATE: 2017-10-24
END MARKETING DATE: 0000-00-00
PRODUCT ID: 71816-0001_5c42f15b-d624-bede-e053-2991aa0a0084
PRODUCT NDC: 71816-0001
APPLICATION NUMBER:

Other MAGNESIUM STEARATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
ISTK3DAYCLING